Related Experiment Video
Updated: May 5, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
Shrikant R Mulay1, Onkar P Kulkarni, Khader V Rupanagudi
1Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
Abstract:
Nephrocalcinosis, acute calcium oxalate (CaOx) nephropathy, and renal stone disease can lead to inflammation and subsequent renal failure, but the underlying pathological mechanisms remain elusive. Other crystallopathies, such as gout, atherosclerosis, and asbestosis, trigger inflammation and tissue remodeling by inducing IL-1β secretion, leading us to hypothesize that CaOx crystals may induce inflammation in a similar manner. In mice, intrarenal CaOx deposition induced tubular damage, cytokine expression, neutrophil recruitment, and renal failure. We found that CaOx crystals activated murine renal DCs to secrete IL-1β through a pathway that included NLRP3, ASC, and caspase-1. Despite a similar amount of crystal deposits, intrarenal inflammation, tubular damage, and renal dysfunction were abrogated in mice deficient in MyD88; NLRP3, ASC, and caspase-1; IL-1R; or IL-18. Nephropathy was attenuated by DC depletion, ATP depletion, or therapeutic IL-1 antagonism. These data demonstrated that CaOx crystals trigger IL-1β-dependent innate immunity via the NLRP3/ASC/caspase-1 axis in intrarenal mononuclear phagocytes and directly damage tubular cells, leading to the release of the NLRP3 agonist ATP. Furthermore, these results suggest that IL-1β blockade may prevent renal damage in nephrocalcinosis.
Insights
Calcium oxalate crystals cause kidney damage by activating the NLRP3 inflammasome in immune cells, leading to inflammation and renal failure. Blocking IL-1β may prevent this kidney damage.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Nephrocalcinosis, calcium oxalate (CaOx) nephropathy, and renal stones can cause kidney failure, but mechanisms are unclear.
- Other crystal-induced diseases involve IL-1β secretion, suggesting a similar pathway for CaOx.
Purpose of the Study:
- To investigate if CaOx crystals induce inflammation via IL-1β in mice.
- To elucidate the molecular pathways involved in CaOx-induced kidney injury.
Main Methods:
- Intrarenal CaOx deposition in mice.
- Assessment of tubular damage, cytokine expression, and neutrophil recruitment.
- Genetic deficiency studies (MyD88, NLRP3, ASC, caspase-1, IL-1R, IL-18).
- DC depletion, ATP depletion, and IL-1 antagonism.
Main Results:
- CaOx deposition caused tubular damage, inflammation, and renal failure in mice.
- CaOx crystals activated renal DCs via NLRP3/ASC/caspase-1, inducing IL-1β secretion.
- Inflammation and damage were reduced in mice lacking key inflammasome or IL-1 pathway components.
- DC depletion, ATP depletion, and IL-1 blockade attenuated nephropathy.
Conclusions:
- CaOx crystals activate IL-1β-dependent innate immunity through the NLRP3/ASC/caspase-1 axis in renal mononuclear phagocytes.
- CaOx crystals directly damage tubular cells, releasing ATP, an NLRP3 agonist.
- IL-1β blockade is a potential therapeutic strategy for CaOx-induced nephropathy.
More Related Videos
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi V: Nursing Management
Inflammatory Bowel Disease III: Crohn's Disease
Acute Pancreatitis II: Pathophysiology